e-learning
resources
Virtual 2021
05.09.2021
Biology of lung cancer: preclinical and translational research
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Evaluation expression of miR-146a and miR-155 and inflammatory cytokines in blood of non-small cell lung cancer patients
N. K.Dezfuli (Tehran, Islamic Republic of Iran), S. Alipoor (Tehran, Islamic Republic of Iran), N. Roofchayee (Tehran, Islamic Republic of Iran), S. Seyfi (Tehran, Islamic Republic of Iran), E. Mortaz (Tehran, Islamic Republic of Iran)
Source:
Virtual Congress 2021 – Biology of lung cancer: preclinical and translational research
Session:
Biology of lung cancer: preclinical and translational research
Session type:
E-poster
Number:
1129
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
N. K.Dezfuli (Tehran, Islamic Republic of Iran), S. Alipoor (Tehran, Islamic Republic of Iran), N. Roofchayee (Tehran, Islamic Republic of Iran), S. Seyfi (Tehran, Islamic Republic of Iran), E. Mortaz (Tehran, Islamic Republic of Iran). Evaluation expression of miR-146a and miR-155 and inflammatory cytokines in blood of non-small cell lung cancer patients. 1129
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on Basic translational and clinical research – building a career in paediatric pulmonology- experiences from clinicians in lower middle income countries
ERS/EAACI statement on severe exacerbations in asthma in adults: facts, priorities and key research questions
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Related content which might interest you:
Expression analysis of miR-223 in plasma of patients with non-small cell lung cancer and other obstructive lung diseases
Source: International Congress 2018 – Lung cancer: novel prognostic markers and scores
Year: 2018
Differential cytokine expression in non-small cell lung carcinomas
Source: Eur Respir J 2007; 30: Suppl. 51, 512s
Year: 2007
Importance of clusterin expression at tissue level for the prognosis of non-small cells lung cancer
Source: Annual Congress 2009 - Lung cancer biology
Year: 2009
Impact of PD-L1 expression levels on the response to pembrolizumab in metastatic non-small cell lung cancer>
Source: Virtual Congress 2021 – Screening, diagnosis, management and prognosis of lung cancer
Year: 2021
Macrophage expression of interleukin-10 is a prognostic factor in nonsmall cell lung cancer
Source: Eur Respir J 2007; 30: 627-632
Year: 2007
Vesicle-related microRNAs in plasma of nonsmall cell lung cancer patients and correlation with survival
Source: Eur Respir J 2011; 37: 617-623
Year: 2011
The value of CD44 and MMP-2 expression in non-small cell lung cancer
Source: Eur Respir J 2004; 24: Suppl. 48, 77s
Year: 2004
Role of anlotinib-induced CCL2 decrease in anti-angiogenesis and response prediction for nonsmall cell lung cancer therapy
Source: Eur Respir J, 53 (3) 1801562; 10.1183/13993003.01562-2018
Year: 2019
Survivin expression in non-small cell lung cancer
Source: Annual Congress 2010 - Recent developments of molecular pathology and functional genomics in non-neoplastic and neoplastic lung diseases
Year: 2010
Pleural and systemic cytokine expression profiles in patients with lung cancer
Source: International Congress 2018 – Lung cancer: modern therapies and beyond
Year: 2018
Relationship between blood monocyte subsets with activation markers and macrophages in non-small cell lung cancer
Source: Virtual Congress 2020 – Prognostic and predictive factors: treatment of lung cancer
Year: 2020
Tumour-associated macrophages in nonsmall cell lung cancer: the role of interleukin-10
Source: Eur Respir J 2007; 30: 608-610
Year: 2007
Expression of ERCC1 in normal and tumor tissues in non-small cell lung cancer
Source: Annual Congress 2007 - Biology of thoracic malignancies
Year: 2007
Low miR-145 and high miR-367 are associated with unfavourable prognosis in resected nonsmall cell lung cancer
Source: Eur Respir J 2013; 41: 1172-1178
Year: 2013
Choice of endogenous control for gene expression in nonsmall cell lung cancer
Source: Eur Respir J 2005; 26: 1002-1008
Year: 2005
Abnormal expression of let-7a miRNA in blood of lung cancer patient
Source: Annual Congress 2010 - Biomarkers for lung cancer
Year: 2010
Role of EBUS-TBNA in the study of PD-L1 expression in patients with non-small cell lung cancer (NSCLC)
Source: Virtual Congress 2020 – Endobronchial ultrasound: from rookie to pro
Year: 2020
Apelin expression is a prognostic factor in non-small cell lung cancer
Source: Annual Congress 2010 - Prognostic factors for lung cancer
Year: 2010
Evaluate soluble PD-L1 in plasma in advanced stage non-small cell lung cancer patients
Source: Virtual Congress 2020 – Biological mechanisms of lung cancer
Year: 2020
Expression of βig-h3 as a marker of local tumor invasion in non-small cell lung cancer
Source: Eur Respir J 2006; 28: Suppl. 50, 770s
Year: 2006
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept